Stay updated on Alirocumab for Plaque Regression in PAD Clinical Trial
Sign up to get notified when there's something new on the Alirocumab for Plaque Regression in PAD Clinical Trial page.

Latest updates to the Alirocumab for Plaque Regression in PAD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference12%
- Check23 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%
- Check37 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.7%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference16%
- Check65 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.3%
Stay in the know with updates to Alirocumab for Plaque Regression in PAD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab for Plaque Regression in PAD Clinical Trial page.